Niferex (Avion Pharmaceuticals, LLC)


Welcome to the PulseAid listing for the Niferex drug offered from Avion Pharmaceuticals, LLC. This Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA],Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Avion Pharmaceuticals, LLC
NON-PROPRIETARY NAME: ferrous asparto glycinate, iron, ascorbic acid, folic acid, cyanocobalamin, zinc, succinic acid, and intrinsic factor
SUBSTANCE NAME: FERROUS ASPARTO GLYCINATE; IRON DEXTRAN; ASCORBIC ACID; LEVOMEFOLIC ACID; FOLIC ACID; CYANOCOBALAMIN; ZINC; SUCCINIC ACID; INTRINSIC FACTOR
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Iron [Chemical/Ingredient],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA],Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2017-01-23
END MARKETING DATE: 0000-00-00


Niferex HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNiferex from Avion Pharmaceuticals, LLC
LABELER NAME: Avion Pharmaceuticals, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 50; 100; 60; 750; 250; 25; 15; 50; 100(mg/1; mg/1; mg/1; ug/1; ug/1; ug/1; mg/1; mg/1; mg/1)
START MARKETING DATE: 2017-01-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 75854-321_78267520-cb56-461e-9271-f1ffa21a8b26
PRODUCT NDC: 75854-321
APPLICATION NUMBER:

Other FERROUS ASPARTO GLYCINATE; IRON DEXTRAN; ASCORBIC ACID; LEVOMEFOLIC ACID; FOLIC ACID; CYANOCOBALAMIN; ZINC; SUCCINIC ACID; INTRINSIC FACTOR Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avion Pharmaceuticals, LLCNiferex